Brief: NextCure To Temporarily Delay Starting NC318 Combination Clinical Trial In Lung Cancer

April 13 (Reuters) - NextCure Inc  NXTC.O :
    * NEXTCURE PROVIDES UPDATE ON CLINICAL TRIAL ACTIVITIES DUE
TO
IMPACT OF COVID-19 PANDEMIC
    * NEXTCURE - TO TEMPORARILY DELAY STARTING NC318 COMBINATION
CLINICAL TRIAL IN NON-SMALL CELL LUNG CANCER WITH
STANDARD-OF-CARE CHEMOTHERAPIES
    * NEXTCURE INC - TO TEMPORARILY DELAY INITIATING PHASE 1
PORTION
OF A PHASE 1/2 CLINICAL TRIAL FOR NC410

Source text for Eikon:  ID:nGNX1z3Hnq 
Further company coverage:  NXTC.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on NextCure

See all news